Portfolio (Quarterly)
Guide ↗
NAN FUNG TRINITY (HK) LTD
· CIK 0001781880| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PPG | PPG INDS INC | Basic Materials | 397,334.0 | $42.5M | 4.66% | +128K | +47.4% | $106.88 | -2.2% |
| 2 | KT | KT CORP | Communication Services | 1,950,140.0 | $41.8M | 4.59% | +458K | +30.7% | $21.45 | -9.7% |
| 3 | NVDA | NVIDIA CORPORATION | Technology | 230,140.0 | $40.1M | 4.41% | +36K | +18.2% | $174.40 | +27.4% |
| 4 | THD | ISHARES INC | — | 510,000.0 | $35.4M | 3.89% | +137K | +36.8% | $69.38 | +4.2% |
| 5 | EIDO | ISHARES TR | — | 2,238,900.0 | $35.4M | 3.88% | +1.0M | +83.3% | $15.79 | -21.0% |
| 6 | UNH | UNITEDHEALTH GROUP INC | Healthcare | 104,155.0 | $28.2M | 3.10% | +52K | +98.6% | $270.59 | +39.3% |
| 7 | HD | HOME DEPOT INC | Consumer Cyclical | 72,719.0 | $23.9M | 2.63% | +26K | +54.9% | $328.89 | -8.8% |
| 8 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 232,679.0 | $21.5M | 2.36% | +5K | +2.3% | $92.38 | -0.6% |
| 9 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 219,215.0 | $16.3M | 1.79% | +109K | +99.1% | $74.26 | -10.3% |
| 10 | WBD | WARNER BROS DISCOVERY INC | Communication Services | 575,744.0 | $15.8M | 1.74% | +78K | +15.8% | $27.46 | +1.2% |
| 11 | PDD | PDD HOLDINGS INC | Consumer Cyclical | 152,900.0 | $15.6M | 1.72% | +45K | +41.4% | $102.18 | -22.8% |
| 12 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 247,765.0 | $14.4M | 1.58% | +21K | +9.2% | $58.15 | -31.6% |
| 13 | ABVX | ABIVAX SA | Healthcare | 128,940.0 | $14.4M | 1.58% | +16K | +13.7% | $111.35 | -5.7% |
| 14 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 285,495.0 | $14.0M | 1.54% | +22K | +8.4% | $49.16 | -5.1% |
| 15 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 1,142,950.0 | $13.6M | 1.50% | +226K | +24.6% | $11.93 | +25.3% |
| 16 | CELC | CELCUITY INC | Healthcare | 103,775.0 | $11.8M | 1.30% | +23K | +28.5% | $114.14 | -29.4% |
| 17 | TGT | TARGET CORP | Consumer Defensive | 96,778.0 | $11.7M | 1.29% | +9K | +10.9% | $121.20 | +30.5% |
| 18 | SVRA | SAVARA INC | Healthcare | 1,842,350.0 | $10.1M | 1.10% | +154K | +9.1% | $5.46 | -1.6% |
| 19 | KURA | KURA ONCOLOGY INC | Healthcare | 1,064,880.0 | $8.7M | 0.95% | +100K | +10.4% | $8.13 | +44.3% |
| 20 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 427,885.0 | $8.5M | 0.94% | +56K | +14.9% | $19.89 | +13.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
37.4%
Technology
14.0%
Basic Materials
12.6%
Communication Services
12.2%
Consumer Cyclical
8.8%
Real Estate
8.2%
Industrials
5.0%
Consumer Defensive
1.8%